| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6148c5b519009bb2a4444925cba0d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80801768b94a3f8d6feba118a37ed9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78f9cfa4b62185e810e6504bacf39e20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
| filingDate |
2010-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec853533fb18bdd820a60a4828a54e13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2a3b26b47c61459d0aafa082d69e5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33578a1c770ed4620b4f7a7e8bbe85a0 |
| publicationDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8273742-B2 |
| titleOfInvention |
Disubstituted phthalazine hedgehog pathway antagonists |
| abstract |
The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer. |
| priorityDate |
2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |